ACTRN12615000460505终止1 期
In people with treatment resistant schizophrenia, is sodium benzoate a tolerated and acceptable augmentation strategy: a phase Ib/II study.
niveristy of Otago0 个研究点目标入组 1 人开始时间: 2015年5月12日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •1.A clinical diagnosis of Schizophrenia, confirmed by a structured diagnostic interview.
- •2.Have a body mass index between 18 and 35 (that is, not underweight or markedly overweight)
- •3.Have had no major change in their symptoms for three months.
- •4.Have moderate to severe current symptom
排除标准
- •1.You are pregnant or are intending to become pregnant.
- •2.Have a history of alcohol or drug dependance.
- •3.Have a history of epilepsy, head injury, or a neurological disorder.
- •4.If participating in the trial would place you at unacceptable risk.
- •5.If you are considered highly likely to not take any medications, as part of the study or not.
研究者
相似试验
招募中
不适用
Therapie Resistentie Voorspellen bij SchizofrenieSchizophrenia, treatment resistance, psychosis, schizofrenie, therapie resistentie, psychoseNL-OMON21525Amsterdam UMC, University of Amsterdam100
已完成
不适用
Predicting Treatment Resistance in Schizophreniafirst episode psychosis10039628schizophreniaNL-OMON48828Academisch Medisch Centrum120
终止
3 期
Augmentation of antipsychotic medication with anticonvulsant in the management of treatment resistant schizophreniaMental and Behavioural DisordersSchizophreniaISRCTN77257074King's College London371
已完成
不适用
Assertive Outreach for people with schizophreniaSchizophreniaDRKS00003351euphana Universität Lüneburg341
已完成
不适用
Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulatioSchizophreniaISRCTN93378085Record Provided by the NHSTCT Register - 2007 Update - Department of Health12